The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Comparative effectiveness of palbociclib plus aromatase inhibitor versus fulvestrant alone as initial endocrine therapy for HR+/HER2- advanced breast cancer in Chinese clinical practice: A real-world study.
 
Jian Yue
No Relationships to Disclose
 
Peng Yuan
No Relationships to Disclose
 
Xue Wang
No Relationships to Disclose
 
Jie Ju
No Relationships to Disclose
 
Song-lin Gao
No Relationships to Disclose
 
Zixuan Yang
No Relationships to Disclose
 
Yikun Kang
No Relationships to Disclose
 
Zixuan Lei
No Relationships to Disclose
 
You Shuai
No Relationships to Disclose
 
Tong Wei
No Relationships to Disclose